Generic name |
levodopa/carbidopa/entacapone |
---|---|
Strength |
|
Form |
tablet |
Special Authority criteria |
Approval period |
---|---|
As adjunct therapy for patients with an inadequate response (defined as significant "wearing off" and/or severe motor complications i.e. fluctuations) after alterations of levodopa/carbidopa doses. |
Indefinite |